Tisagenlecleucel for B-Cell acute lymphoblastic leukemia and diffuse large B-Cell lymphoma project protocol, clinical section

Detalles Bibliográficos
Autor principal: Canadian Agency for Drugs and Technologies in Health (author)
Autor Corporativo: Canadian Agency for Drugs and Technologies in Health, author, issuing body (author)
Formato: Libro electrónico
Idioma:Inglés
Publicado: Ottawa, Ontario : Canadian Agency for Drugs and Technologies in Health [2018]
Colección:CADTH optimal use report ; Number 8.3a.
Materias:
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820392706719
Descripción
Descripción Física:1 online resource (19 pages) : illustrations